A priority review voucher program to fuel generic drug development

Health Affairs

6 July 2023 - Millions of Americans report that they are unable to fill their prescriptions or are not taking their medications as prescribed because they cannot afford them, generating bipartisan interest in curbing the rapid rise of drug prices. 

Opinions diverge on how best to approach this problem while also preserving access and innovation, but small molecule generic drugs have historically offered significant cost savings that have contributed to keeping a portion of health care spending from spiralling out of control.

Read Health Affairs article

Michael Wonder

Posted by:

Michael Wonder